ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Diagnostic evaluation for suspected physical child abuse

Diagnostic evaluation for suspected physical child abuse
Patient characteristic Order/action
INITIAL EMERGENCY EVALUATION
  • All patients
Report to child protective services (where applicable)
Consult (directly contact consultant):
  • Social work
  • Child abuse specialist/team
  • Trauma surgery
  • Infant <6 months old, regardless of physical findings
  • Infant 6 to <12 months old with external head injuries on examination OR skull fracture OR fracture highly suggest of abuse (eg, rib fractures or metaphyseal fractures)
  • Child of any age with signs suggesting intracranial injury
Perform neuroimaging:
  • Head CT*
  • All children <2 years old
  • Child <5 years old AND (neurologically impaired OR distracting injury OR suspicious index fracture)
Perform skeletal survey radiographs
  • Infant <6 months of age
  • Older child with trunk bruising or significant injury (eg, fracture, intracranial hemorrhage)
Screen for abdominal injury:
  • AST
  • ALT
  • Lipase

AST OR ALT >80; lipase >100:

  • CT abdomen with intravenous contrast (no oral contrast)
  • Child with bruising or bleeding
Screen for bleeding disorder:Δ
  • CBC with platelets
  • PT, INR, aPTT
  • VWF antigen
  • VWF activity
  • Factor VIII level
  • Factor IX level
  • Factor XIII level (if intracranial bleeding)
  • D-dimer (if intracranial bleeding)
  • Fibrinogen (if intracranial bleeding)
  • Children with suspected drug exposure, poisoning, or symptoms suggesting drug toxicity
  • Serum and urine toxicology screen
FURTHER EVALUATION
  • Child with intracranial bleeding
Screen for metabolic disease:
  • Urine organic acids
  • Plasma amino acids
  • Child with suspected abusive head trauma, periorbital bruising, or eye injury
Identify retinal hemorrhages:
  • Ophthalmology consult within 72 hours§
  • Child with concern for abuse due to fracture(s)
Screen for metabolic bone disease:¥
  • Serum calcium and phosphorus
  • Serum alkaline phosphatase
  • Intact parathyroid hormone level
  • 25-OH vitamin D level

When osteogenesis imperfecta is suspected:¥

  • COL 1A1, COL 1A2, IFITM5 gene sequence
  • Male infant <6 months old with fracture
Screen for Menkes disease:
  • Serum copper level
  • Serum ceruloplasmin level
  • Child with symptomatic neurologic injury
Evaluate for cervical spine soft tissue and additional brain injury:
  • At 2 days, MRI of cervical spine and brain
  • All children with continued suspicion of physical child abuse after the initial evaluation
Evaluate for healing initially undiagnosed fractures:
  • At 2 weeks, repeat skeletal survey radiographs; omit skull, lateral spine, and pelvis views
This table provides suggested studies to evaluate for child physical abuse based upon patient age and specific type of injury. Consultation with a child abuse team led by a child abuse specialist is encouraged to guide testing in specific patients. For more detailed information, refer to UpToDate content on the recognition and diagnosis of physical child abuse. This table does not apply to the evaluation of child neglect or sexual abuse.

CT: computed tomography; AST: aspartate transaminase; ALT: alanine transaminase; CBC: complete blood count; PT: prothrombin time; INR: international normalized ratio; aPTT: activated partial thromboplastin time; VWF: von Willebrand factor; MRI: magnetic resonance imaging.

* Brain MRI instead of head CT is acceptable for initial neuroimaging of asymptomatic children when MRI and pediatric neuroradiologist interpretation are readily available within a few hours.

¶ While some child abuse specialists will recommend these studies in all cases, it may be reasonable to omit them when the diagnosis of abuse is more secure due to witnessed abuse, confessed abuse, skin injuries with the imprint of an object or hand, or multiple injuries not explainable by a single medical condition.

Δ For patients with abnormal testing results, or if further testing is desired, consult a pediatric hematologist.

◊ Studies beyond the typical rapid drugs of abuse screens may also be warranted. Consultation with medical toxicologist or regional poison control center is advised.

§ Examination within 48 hours is preferred, when possible.

¥ Consult a pediatric endocrinologist for patients with abnormal testing results.

‡ Consult a geneticist to interpret results in light of the patient's phenotype.
Graphic 119442 Version 2.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟